SGLT2i: Therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?

Jiajia Wu; Hong Cai; Jia Xia; Tianyi Zhang; Jiayi Yan; Xinhua Shao; Amanda Ying Wang; Jianxiao Shen; Shan Mou

doi:10.1016/j.phrs.2023.106883

SGLT2i: Therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?

Pharmacol Res. 2023 Sep:195:106883. doi: 10.1016/j.phrs.2023.106883. Epub 2023 Aug 5.

Authors

Jiajia Wu¹, Hong Cai¹, Jia Xia¹, Tianyi Zhang¹, Jiayi Yan¹, Xinhua Shao¹, Amanda Ying Wang², Jianxiao Shen³, Shan Mou⁴

Affiliations

¹ Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
² The Faculty of Medicine and Health Sciences, Macquarie University, NSW Australia, Australia; The Renal and Metabolic Division, George Institute for Global Health, UNSW, Australia; Department of Renal Medicine, Concord Clinical School, The University of Sydney, Australia. Electronic address: Awang@georgeinstitute.org.au.
³ Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address: shenjianxiao@aliyun.com.
⁴ Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address: moushanrenji@126.com.

PMID: 37544050
DOI: 10.1016/j.phrs.2023.106883

No abstract available

Keywords: Contrast induced acute kidney injury (CI-AKI); Non-diabetes; Predisposing factors; Sodium-glucose cotransporter 2 inhibitors (SGLT2i); Treatment measures.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acute Kidney Injury* / chemically induced
Acute Kidney Injury* / drug therapy
Diabetes Mellitus, Type 2* / drug therapy
Glucose
Humans
Hypoglycemic Agents / therapeutic use
Retrospective Studies

Substances

Hypoglycemic Agents
Glucose